Net Drug Cost definition

Net Drug Cost means the price Medco charges a Client Plan and/or Patient for a prescription drug whether that drug is delivered through a retail pharmacy or mail order. The Net Drug Cost may take into account all discounts, rebates, credits or other payments that lower the cost of the drug, to the extent such payments are provided to the Client Plan. Net Drug Cost may be reduced by Manufacturer Payments to the extent those payments are provided to the Client Plan, but shall not be reduced by Manufacturer Payments that are paid to and retained by Medco.
Sample 1Sample 2
Net Drug Cost means the price Medco charges a Client Plan and/or Patient for a
Sample 1Sample 2
Net Drug Cost means the price Medco charges a Client Plan and/or Patient for a prescription drug whether that drug is delivered through a retail pharmacy or mail order. The Net Drug Cost may take into account all discounts, rebates, credits or other payments that lower the cost of the drug, to the extent such payments are provided to the Client Plan. Net Drug Cost may be reduced by Manufacturer Payments to the extent those payments are provided to the ClientPlan, but shall not be reduced by Manufacturer Payments that are paid to and retained by Medco. “Patient” shall mean a person whose prescription drug benefit is administered by Medco. “P&T Committee” shall mean the Pharmacy & Therapeutics Committee maintained byMedco, comprised of at least seven members, all of whom shall be physicians, pharmacists, or other health care professionals, and a majority of whom are actively practicing and who are not employed by Medco, responsible for determining Medco’s standard formularies, the clinical appropriateness for Medco concerning Medco’s Drug Interchange programs, developing and maintaining clinical criteria used as a basis for Medco’s standard coverage management program and other responsibilities pertaining to the clinical components of programs and services designed to effect drug utilization.
Sample 1

Examples of Net Drug Cost in a sentence

  • Make any Drug Interchange Solicitation where the Net Drug Cost of the Proposed Drug exceeds that of the Currently Prescribed Drug.

  • The Gift must be utilized within 3 months from the date of the SMS notification , failing which the Gift shall be null and void and the Gift shall be forfeited.

  • Mike calculated that the total cost for the addition would be 300 bags of rice.

  • None of the drugs identified were on the previous year’s list.o DVHA Net Drug Cost Analysis: This list contains drugs for which the net cost to DVHA increased by 15% or more in CY 2020.

  • Two of the drugs identified were on the previous year’s list.o DVHA Net Drug Cost Analysis: This list contains drugs for which the net cost to DVHA increased by 15% or more in CY 2021.

  • None of the drugs identified were on the previous year’s list.o DVHA Net Drug Cost Analysis: This list contains drugs for which the net cost to DVHA increased by 15% or more in CY2019.

  • Whenever a Drug Interchange is considered for a multi-sourced drug, Caremark shall request that a generic drug be prescribed, if one exists, before requesting that another brand drug be substituted, unless the brand drug has a lower Net Drug Cost than the generic drug.

  • Make any Drug Interchange Solicitation where the Net Drug Cost of the Proposed9 Drug exceeds that of the Currently Prescribed Drug.

  • Make any Drug Interchange Solicitation where the Currently Prescribed Drug has13 generic equivalents and the Proposed Drug has no generic equivalents, unless the Proposed Drug has a14 lower Net Drug Cost than all generic equivalents of the Currently Prescribed Drug.15 3.

  • Medco shall allocate Bundled Drug rebates and10 discounts to the Net Drug Cost of each drug in the manner agreed to between Medco and the Client11 Plan.12 2.

Related to Net Drug Cost

  • Manufacturing Cost means [***].

  • Fully Burdened Manufacturing Cost means, with respect to any Licensed Product supplied by or on behalf of NVCR to Zai hereunder if such Licensed Product (or any precursor or intermediate thereof) is manufactured by a Third Party manufacturer [***].

  • Development Cost means the total of all costs incurred in the completion of a Development excluding Developer Fee, operating deficit reserves, and total land cost as typically shown in the Development Cost line item on the development cost pro forma.

  • Manufacturing Costs means the costs of Processing that generate Manufacturing Proceeds received by Grantor.

  • Net cost means the Contractor’s actual cost after deducting all permitted cash and trade discounts, rebates, allowances, credits, sales taxes, commissions, and refunds (whether or not any or all of the same shall have been taken by the Contractor) of all parts and materials purchased by the Contractor solely for the use in performing its obligation hereunder provided, where such purchase has received the prior written approval of the Manager as required herein. The Contractor shall promptly furnish to the Manager such bills of sale and other instruments as the Manger may require, executed, acknowledged and delivered, assuring to the Manager title to such materials, supplies, equipment, parts, and tools free of encumbrances.

  • FTE Cost means, for any period, the FTE Rate multiplied by the number of FTEs in such period.

  • Base Cost means base cost as defined in paragraph 1 of the Eighth Schedule;

  • GDP or “Gross Domestic Product” for the purposes of this LOA means the expenditure side value of all goods and services produced in British Columbia for a given year as stated in the BC Economic Accounts;

  • Total Development Cost means the total of all costs incurred in the completion of a Development, all of which shall be subject to the review and approval by the Credit Underwriter and the Corporation pursuant to this rule chapter, and as further described in Rule 67-48.0075, F.A.C.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • CPI Daily Inflation Reference Index means (A) in relation to the first day of any given month, the CPI Monthly Reference Index of the third month preceding such month, and (B) in relation to a day (D) (other than the first day) in any given month (M), the linear interpolation of the CPI Monthly Reference Index pertaining respectively to the third month preceding such month (M - 3) and the second month preceding such month (M - 2) calculated in accordance with the following formula:

  • Maximum allowable cost list means a list of drugs for

  • The Contract Price/Project Cost means the price payable to the Vendor under the Contract for the full and proper performance of its contractual obligations.

  • Allowable Cost means a cost that complies with all legal requirements that apply to a particular federal education program, including statutes, regulations, guidance, applications, and approved grant awards.

  • Life-cycle cost means the expected total cost of ownership during the life of a product, including disposal costs.

  • Development Costs means costs incurred to obtain access to reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas from reserves. More specifically, development costs, including applicable operating costs of support equipment and facilities and other costs of development activities, are costs incurred to:

  • Project Cost means the price payable to Service Provider over the entire period of Agreement (i.e. Rs. <in words>) for the full and proper performance of its contractual obligations.

  • Patient cost means the cost of a medically necessary health care service that is incurred as a result

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • HICP Daily Inflation Reference Index means (A) in relation to the first calendar day of any given month, the HICP Monthly Reference Index of the third month preceding such month, and (B) in relation to a calendar day (D) (other than the first calendar day) in any given month (M), the linear interpolation of the HICP Monthly Reference Index pertaining respectively to the third month preceding such month (M - 3) and the second month preceding such month (M - 2) calculated in accordance with the following formula:

  • Marketing Costs which means such reasonable charge for marketing of ores and concentrates sold or of concentrates tolled as is consistent with generally accepted industry marketing practices;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Estimated Project Cost means Benchmark cost of MNRE which is Rs 8.00 Crore/MWp as per MNRE letter no. 03/20/2014-15/GCRT/11.12.14 at the time of Bid Due date.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Target Cost as used in this contract, means the estimated cost of this contract as initially negotiated, adjusted in accordance with paragraph (d) of this clause.